Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell Vang

Showing results (101-110 of 155) with videos related to

Pageof 16
Sort By:
Human Pathology|August 7, 2013
A subset of malignant phyllodes tumors harbors alterations in the Rb/p16 pathwayAshley Cimino-Mathews, Jessica L Hicks, Rajni Sharma, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 10, 2024
Early Genetic Divergence of High-Grade Carcinomas Originating from Low-Grade Serous Ovarian NeoplasmsM Herman Chui, Qianqian Song, Jiarun Zhu, et al.
The Journal of Pathology|December 6, 2013
Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implantsLaura Ardighieri, Felix Zeppernick, Charlotte G Hannibal, et al.
The American Journal of Surgical Pathology|July 7, 2022
Twin/Multiple Gestations With a Hydatidiform Mole: Clinicopathologic Analysis of 21 Cases With Emphasis on Molecular Genotyping and Parental ContributionDeyin Xing, Emily Adams, Ying S Zou, et al.
Gynecologic Oncology|April 6, 2007
The role of cytoreductive surgery for colon cancer metastatic to the ovaryColleen C McCormick, Robert L Giuntoli, Ginger J Gardner, et al.
The American Journal of Surgical Pathology|September 5, 2014
BRAF mutation is associated with a specific cell type with features suggestive of senescence in ovarian serous borderline (atypical proliferative) tumorsFelix Zeppernick, Laura Ardighieri, Charlotte G Hannibal, et al.
The American Journal of Surgical Pathology|January 17, 2012
Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosisRussell Vang, Mamta Gupta, Lee-Shu-Fune Wu, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 2, 2021
Adult Granulosa Cell Tumor With Sarcomatous Transformation: A Case Study With Emphasis on Molecular AlterationsWissam Dahoud, Jesse Handler, Vamsi Parimi, et al.
Histopathology|December 15, 2025
Ovarian Sertoli-Leydig cell tumors with heterologous rhabdomyosarcoma: Clinicopathologic features and molecular analysis highlighting recurrent genetic alterationsYing S Zou, Sanobar Yasmeen Mohammed, Jing Zhu, et al.
Oncotarget|September 11, 2015
Molecular analysis of ovarian mucinous carcinoma reveals different cell of originsYihong Wang, Lauren Ende Schwartz, Derek Anderson, et al.
Pageof 16

Showing results (101-110 of 155) with videos related to

Sort By:
Pageof 16
Human Pathology|August 7, 2013
A subset of malignant phyllodes tumors harbors alterations in the Rb/p16 pathwayAshley Cimino-Mathews, Jessica L Hicks, Rajni Sharma, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 10, 2024
Early Genetic Divergence of High-Grade Carcinomas Originating from Low-Grade Serous Ovarian NeoplasmsM Herman Chui, Qianqian Song, Jiarun Zhu, et al.
The Journal of Pathology|December 6, 2013
Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implantsLaura Ardighieri, Felix Zeppernick, Charlotte G Hannibal, et al.
The American Journal of Surgical Pathology|July 7, 2022
Twin/Multiple Gestations With a Hydatidiform Mole: Clinicopathologic Analysis of 21 Cases With Emphasis on Molecular Genotyping and Parental ContributionDeyin Xing, Emily Adams, Ying S Zou, et al.
Gynecologic Oncology|April 6, 2007
The role of cytoreductive surgery for colon cancer metastatic to the ovaryColleen C McCormick, Robert L Giuntoli, Ginger J Gardner, et al.
The American Journal of Surgical Pathology|September 5, 2014
BRAF mutation is associated with a specific cell type with features suggestive of senescence in ovarian serous borderline (atypical proliferative) tumorsFelix Zeppernick, Laura Ardighieri, Charlotte G Hannibal, et al.
The American Journal of Surgical Pathology|January 17, 2012
Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosisRussell Vang, Mamta Gupta, Lee-Shu-Fune Wu, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 2, 2021
Adult Granulosa Cell Tumor With Sarcomatous Transformation: A Case Study With Emphasis on Molecular AlterationsWissam Dahoud, Jesse Handler, Vamsi Parimi, et al.
Histopathology|December 15, 2025
Ovarian Sertoli-Leydig cell tumors with heterologous rhabdomyosarcoma: Clinicopathologic features and molecular analysis highlighting recurrent genetic alterationsYing S Zou, Sanobar Yasmeen Mohammed, Jing Zhu, et al.
Oncotarget|September 11, 2015
Molecular analysis of ovarian mucinous carcinoma reveals different cell of originsYihong Wang, Lauren Ende Schwartz, Derek Anderson, et al.
Pageof 16